Limits of transforming competence of SV40 nuclear and cytoplasmic large T mutants with altered Rb binding sequences.
Multiple amino acid substitutions were introduced into the SV40 large T region that harbors the retinoblastoma protein (Rb) binding site and the nuclear transport signal, changing either one or both of these determinants. Mutant activities were examined in a set of assays allowing different levels of transforming potential to be distinguished; phenotypic changes in established and pre-crisis rat embryo fibroblasts (REFs) were detected under isogenic cell conditions, and comparisons made with other established rodent cells. The limit of the transforming ability of mutants with important substitutions in the Rb binding site fell between two transformation levels of the same established rat cells. Such cells could be induced to form dense foci but not agar colonies (their parental pre-crises REFs, as expected, were untransformed either way). Nonetheless, agar colony induction was possible in other cell lines, such as mouse NIH3T3 and (for one of the mutants) rat F2408. All these mutants efficiently immortalized pre-crisis REFs. The transforming ability of cytoplasmic mutants appeared to depend on the integrity of the Rb-binding sequence to approximately the same extent as that of the wild-type large T, although evidence of in vivo Rb-cytoplasmic large T complexes was not found. The presence or absence of small t was critical when the transforming task of mutants was near the limit of their abilities.
Tedesco
D
D
Instituto di Biologia Cellulare del CNR, Rome, Italy.
Fischer-Fantuzzi
L
L
Vesco
C
C
D000595:Amino Acid Sequence; D000818:Animals; D000952:Antigens, Polyomavirus Transforming / Q000737:chemistry / Q000276:immunology / Q000494:pharmacology*; D001665:Binding Sites; D002471:Cell Transformation, Neoplastic; D008969:Molecular Sequence Data; D009154:Mutation; D011233:Precipitin Tests; D051381:Rats; D016160:Retinoblastoma Protein / Q000276:immunology / Q000378:metabolism*; D013539:Simian virus 40 / Q000276:immunology*; D013329:Structure-Activity Relationship
D000952:Antigens, Polyomavirus Transforming; D016160:Retinoblastoma Protein